Literature DB >> 21647639

IVM is an alternative for patients with PCO after failed conventional IVF attempt.

Bulent Gulekli1, Muge Kovali, Fulya Aydiner, Sule Dogan, Seda S Dogan.   

Abstract

PURPOSE: To determine if IVM of oocytes from unstimulated cycle is a treatment option for patients who did not deliver after standard IVF-ET.
METHOD: Twenty three women with PCO, thirteen of them with normal cycles and all <35 years old, who failed IVF served as their own control. During the control IVF cycle patients were stimulated with 1730.7 ± 639.5 IU recombinant FSH, a long Buserelin acetate protocol was used and embryo transfer was performed on day 2 or 3 after ICSI. After failed IVF immature oocytes were aspirated transvaginally from antral follicles during spontaneous menstrual cycle. Embryo transfer was performed 2 or 3 days later. RESULT: 11.4 ± 4.8 mature oocytes and 6.7 ± 3.2 embryos were produced with IVF, which served as the control, compared to 9.7 ± 4.5 mature oocytes and 6.2 ± 3.2 embryos with IVM. There was one clinical pregnancy in the IVF group which did not result in a live birth where as five singleton and one pair of twins with healthy live births and one miscarriage in the IVM group.
CONCLUSION: IVM does not involve ovarian stimulation with possible financial and health consequences. İt may be an useful treatment after unsuccessful IVF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21647639      PMCID: PMC3158251          DOI: 10.1007/s10815-011-9591-z

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  25 in total

1.  Ultrasonographic assessment of endometrial receptivity at embryo transfer in an in vitro maturation of oocyte program.

Authors:  Tim J Child; Bulent Gulekli; Camille Sylvestre; Seang Lin Tan
Journal:  Fertil Steril       Date:  2003-03       Impact factor: 7.329

2.  Women's experience of IVF: a follow-up study.

Authors:  K Hammarberg; J Astbury; H Baker
Journal:  Hum Reprod       Date:  2001-02       Impact factor: 6.918

3.  The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization.

Authors:  Michèle Hansen; Jennifer J Kurinczuk; Carol Bower; Sandra Webb
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

4.  Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome.

Authors:  R C Chian; W M Buckett; T Tulandi; S L Tan
Journal:  Hum Reprod       Date:  2000-01       Impact factor: 6.918

5.  Pregnancy and delivery after cryopreservation of zygotes produced by in-vitro matured oocytes retrieved from a woman with polycystic ovarian syndrome.

Authors:  R C Chian; B Gülekli; W M Buckett; S L Tan
Journal:  Hum Reprod       Date:  2001-08       Impact factor: 6.918

6.  Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome.

Authors:  R C Chian; B Gülekli; W M Buckett; S L Tan
Journal:  N Engl J Med       Date:  1999-11-18       Impact factor: 91.245

7.  Neonatal outcome and congenital malformations in children born after in-vitro fertilization.

Authors:  Sari Koivurova; Anna-Liisa Hartikainen; Mika Gissler; Elina Hemminki; Ulla Sovio; Marjo-Riitta Järvelin
Journal:  Hum Reprod       Date:  2002-05       Impact factor: 6.918

8.  A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries.

Authors:  Tim J Child; Simon J Phillips; Ahmad Kamal Abdul-Jalil; Bulent Gulekli; Seang Lin Tan
Journal:  Obstet Gynecol       Date:  2002-10       Impact factor: 7.661

9.  In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography.

Authors:  Seang Lin Tan; Timothy J Child; Bulent Gulekli
Journal:  Am J Obstet Gynecol       Date:  2002-04       Impact factor: 8.661

10.  In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome.

Authors:  T J Child; A K Abdul-Jalil; B Gulekli; S L Tan
Journal:  Fertil Steril       Date:  2001-11       Impact factor: 7.329

View more
  6 in total

1.  Comparison of in vitro maturation and in vitro fertilization for polycystic ovary syndrome patients: a systematic review and meta-analysis.

Authors:  Yalan Xu; Jie Qiao
Journal:  Ann Transl Med       Date:  2021-08

2.  A threshold concentration of FSH is needed during IVM of ex vivo collected human oocytes.

Authors:  Jesús Cadenas; Dmitry Nikiforov; Susanne Elisabeth Pors; Lenin Arturo Zuniga; Yu Wakimoto; Zeinab Ghezelayagh; Linn Salto Mamsen; Stine Gry Kristensen; Claus Yding Andersen
Journal:  J Assist Reprod Genet       Date:  2021-05-28       Impact factor: 3.357

3.  Ultrastructural characteristics of human oocytes vitrified before and after in vitro maturation.

Authors:  Yolanda Segovia; Noemí Victory; Irene Peinado; Laura M García-Valverde; Magdalena García; Jon Aizpurua; Ana Monzó; María José Gómez-Torres
Journal:  J Reprod Dev       Date:  2017-04-30       Impact factor: 2.214

Review 4.  Oocyte in vitro maturation: A sytematic review.

Authors:  Şafak Hatırnaz; Barış Ata; Ebru Saynur Hatırnaz; Michael Haim Dahan; Samer Tannus; Justin Tan; Seang Lin Tan
Journal:  Turk J Obstet Gynecol       Date:  2018-06-21

5.  Ultrastructure of immature and mature human oocytes after cryotop vitrification.

Authors:  Maria Grazia Palmerini; Monica Antinori; Marta Maione; Fabrizio Cerusico; Caterina Versaci; Stefania Annarita Nottola; Guido Macchiarelli; Mohammad Ali Khalili; Severino Antinori
Journal:  J Reprod Dev       Date:  2014-08-28       Impact factor: 2.214

6.  The use of in vitro maturation in stimulated antagonist in vitro fertilization cycles of normo-hyperresponder women due to arrested follicular development: A rescue procedure.

Authors:  Şafak Hatırnaz; Süleyman Akarsu; Ebru Saynur Hatırnaz; Ahmet Zeki Işık; Michael Haim Dahan
Journal:  Turk J Obstet Gynecol       Date:  2018-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.